about
Self-Styled ZnO Nanostructures Promotes the Cancer Cell Damage and Supresses the Epithelial Phenotype of GlioblastomaStudy on different molecular weights of chitosan as an immobilization matrix for a glucose biosensor.Retrospective data analysis and proposal of a practical acceptance criterion for inter-laboratory cross-validation of bioanalytical methods using liquid chromatography/tandem mass spectrometry.Determination of propranolol concentration in small volume of rat plasma by HPLC with fluorometric detection.Determination of abacavir in human plasma by high-performance liquid chromatography with ultraviolet detection and the analytical error function.An enzymatic fluorimetric assay for glucose-6-phosphate: application in an in vitro Warburg-like effectDetermination of GABA, glutamate and carbamathione in brain microdialysis samples by capillary electrophoresis with fluorescence detection.Development of models for predicting the predominant taste and odor compounds in Taihu Lake, China.Simultaneous quantification of tramadol and O-desmethyltramadol in hair samples by gas chromatography-electron impact/mass spectrometry.Pharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor -CR8- in mice.A fluorescence-coupled assay for gamma aminobutyric acid (GABA) reveals metabolic stress-induced modulation of GABA content in neuroendocrine cancer.An enzymatic colorimetric assay for glucose-6-phosphate.Toxicological screening of human plasma by on-line SPE-HPLC-DAD: identification and quantification of basic drugs and metabolites.Development of an amperometric-based glucose biosensor to measure the glucose content of fruit.Toxicological screening of human plasma by on-line SPE-HPLC-DAD: identification and quantification of acidic and neutral drugs.Characterization of the permeability barrier of human skin in vivo.Analytical laboratory quality: Part II. Analytical method validation.Bioanalysis in drug discovery and development.Quantitative acylcarnitine determination by UHPLC-MS/MS--Going beyond tandem MS acylcarnitine "profiles".Regulated drug bioanalysis for human pharmacokinetic studies and therapeutic drug management.Bioanalytical method validation: An updated review.Procedure for the Selection and Validation of a Calibration Model I-Description and Application.Nanoemulsion formulation of florfenicol improves bioavailability in pigs.Development and validation of an LC-MS/MS method for quantification of Δ9-tetrahydrocannabinolic acid A (THCA-A), THC, CBN and CBD in hair.Evaluation of an isochronic study design for long-term frozen stability investigation of drugs in biological matrices.Transepithelial transport characteristics of the antihypertensive peptide, Lys-Val-Leu-Pro-Val-Pro, in human intestinal Caco-2 cell monolayers.Matrix effect and recovery terminology issues in regulated drug bioanalysis.Procedure for the Selection and Validation of a Calibration Model II-Theoretical Basis.Effects of torsemide on pharmacodynamics and pharmacokinetics of warfarin in humans and rats.Determination of RSD921 in human plasma by high-performance liquid chromatography-tandem mass spectrometry using tri-deuterated RSD921 as internal standard: application to a phase I clinical trial.Lidocaine in the horse: its pharmacological effects and their relationship to analytical findings.Pharmacokinetics of doxazosin gastrointestinal therapeutic system after multiple administration in Korean healthy volunteers.High Performance Liquid Chromatographic Determination of Flurbiprofen in Pharmaceutical Dosage FormsAnalytical Method Development and Validation for the Academic ResearcherSensitive Analysis of Prednisolone and Prednisone in Human Plasma by Reverse Phase High-Performance Liquid Chromatography with Ultraviolet Detection
P2860
Q28385157-6879DDEF-FD3D-439D-8642-BA605588BECAQ30450938-98CBBF47-DFCB-4841-BCD2-C43C24D947CFQ30842882-CA9C36FC-E8ED-4D5F-9C0A-314F301A8BF2Q31032735-B81038C9-233E-497C-989B-487331C6D0D8Q33207117-63526B72-4D0E-4128-8B65-916EAE2837E2Q33766264-C448D71B-E939-427C-B8AD-C680200280FAQ34433835-3F62C3D0-03A4-428D-9552-607BCBF42568Q34532653-053757B6-EAE6-4A81-86B1-7D7255FCF3C6Q34631466-AF064D93-4A03-48C8-8B50-89738F711406Q35002296-D8DF393D-A0C2-4F42-B21F-486EB30CA594Q35097478-73C8348E-52F8-4537-B8F8-92C744EA85A3Q35375138-D7AA7629-0283-4DAE-BB53-D44B2B7F3A10Q35423794-9F2E9419-E6D0-41AB-9413-442A9AB6EDC9Q35581231-98C2984A-14C3-4696-9B01-F93B36E3F395Q35683938-D57CFABB-8A4A-4C4B-A63B-2C5514C71525Q35999189-851AC7DD-CE4A-45D1-8A12-814E74D9A6DFQ36537174-BD5346C4-8E9D-4748-8970-21A643E75E5EQ36855961-A786D4EC-123D-4F09-BBEB-63A981472E25Q37227910-433247A2-2E7D-4114-AB22-99DCFB8CEE8CQ38040177-2163EBC7-F10A-4471-8642-DC46B563469DQ38115536-4BF3F564-0D43-49FE-A312-4FBDDB98AF0DQ38991271-F9355C87-BD74-4A61-B3D5-377DB7A76023Q41043023-4949B0F9-F3BB-431A-9EAC-529CF958EBA4Q43642236-171FE685-C18B-4C79-A01E-559A84A170F8Q45428835-7365231F-4BBB-4729-B72B-0D0A906ABE87Q46128902-D99D6D68-6C75-4DA6-8E41-C224A7350373Q46828138-2A4BA1BC-F7AF-4CCC-9A6F-1AA0655BE9EEQ47985704-112252A5-397D-482E-B3AA-C02EF92AA08EQ50849656-460A7554-63E4-489D-AAF4-6CE4EC82ED78Q51340485-664FFB33-BB24-4B78-897F-C4F2DE3298EEQ51481436-B8F6C68A-0DCA-401F-8EEC-E00ECA8867DEQ51740165-B6A395CE-9346-434B-BB29-118D20792A52Q58287509-C61EF5D7-2A60-4F10-BDBA-57E24D772878Q58297419-8F39255E-F449-4F19-A58C-2F1B8D22B266Q58302321-4950D587-6D68-40A4-A54F-28FB14B7B895
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Validation of bioanalytical methods.
@en
Validation of bioanalytical methods.
@nl
type
label
Validation of bioanalytical methods.
@en
Validation of bioanalytical methods.
@nl
prefLabel
Validation of bioanalytical methods.
@en
Validation of bioanalytical methods.
@nl
P2093
P356
P1476
Validation of bioanalytical methods.
@en
P2093
P304
P356
10.1023/A:1015882607690
P577
1991-04-01T00:00:00Z